Carbonic anhydrase activators: High affinity isozymes I, II, and IV activators, incorporating a β-alanyl-histidine scaffold

Journal of Medicinal Chemistry

Volumn 45, Issue 2, 2002, Pages 284-291

  Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONIC ANHYDRASE ACTIVATOR; CARNOSINE; CYANAMIDE; ENZYME ACTIVATOR; ISOENZYME; TRIPEPTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; X RAY CRYSTALLOGRAPHY;

ANIMALS; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE IV; CATTLE; DIPEPTIDES; ENZYME ACTIVATORS; ERYTHROCYTES; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037122754     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010958k     Document Type: Article

References (44)

1. Sulphanilamide as a specific inhibitor of carbonic anhydrase
2. Das ferment kohlensäureanhydrase im tierkörper
3. Die aktivatoren der kohlensäureanhydrase
4. Die messmethoden zur untersuchung der katalytischen wirksamkeit der kohlensäureanhydrase
5. Carbonic anhydrase inhibitors
6. Carbonic anhydrase inhibitors and their therapeutic potential
7. Die aktivierung der kohlensäureanhydrase
8. Carbonic anhydrase: Its properties, distribution and significance for carbon dioxide transport
9. Activation of carbonic anhydrase isozymes
10. A reinvestigation of the question of activators of carbonic anhydrase
11. The effect of substrate concentration, pH and other factors upon the activity of carbonic anhydrase
12. Carbonic anhydrase: Chemistry, physiology and inhibition
13. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine
14. A ternary complex of carbonic anhydrase: X-ray crystallographic structure of the adduct of human carbonic anhydrase II. With the activator phenylalanine and the inhibitor azide
15. Pharmacological enhancement of synaptic efficacy, spatial learning and memory through carbonic anhydrase activation in rats
16. Neurochemical enzyme changes in Alzheimer's and Pick's disease
17. Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties
18. Carbonic anhydrase activators. Amino acyl/dipeptidyl histamine derivatives bind with high affinity to isozymes I, II and IV and act as efficient activators
19. Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole
20. Carbonic anhydrase activators. Synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives)
21. Carbonic anhydrase activators. Part 21. Novel activators of isozymes I, II and IV incorporating carboxamido- and ureido histamine moieties
22. Carbonic anhydrase activators. Synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole
23. Carbonic anhydrase activators. 3. Structure-activity correlations for a series of isozyme II activators
24. Carnosine: Its properties, functions and potential therapeutic applications
25. Carnosine protects against methylglyoxal-mediated modifications
26. Carnosine, a protective, anti-ageing peptide?
27. Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-β-alanine hydroxamate moieties
28. Protease inhibitors. Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties
29. Protease inhibitors: Synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methyl-sulfonyl-isourea moieties at P1
30. Carbonic anhydrase activators. VII. Isozyme II activation by bis-azolylmethanes, -ethanes and related azoles
31. Carbonic anhydrase activators. XV. A kinetic study of the interaction of bovine isozyme with pyrazoles, bis- and tris-azolyl methanes
32. Carbonic anhydrase activators. Part 14. Synthesis of mono and bis pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole and their interaction with isozyme II
33. Carbonic anhydrase activators. Part 17. Synthesis and activation studies of a series of 1-(1,2,4-triazole-1H-3-yl)-2,4,6-trisubstituted-pyridinium salts against isozymes I, II and IV
34. Design of carbonic anhydrase inhibitors and the relationship between the pharmacodynamics and pharmacokinetics of acetazolamide
35. The catalytic versatility of erythrocyte carbonic anhydrase. III. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate
36. Carbonic anhydrase II deficiency syndrome: Clinical delineation, interpretation and implications
37. Human carbonic anhydrases and carbonic anhydrase deficiencies
38. Fine-tuning of the catalytic properties of carbonic anhydrase. Studies of a Thr200-His variant of human isoenzyme II
39. Structure-function relations in human carbonic anhydrase II as studied by site-directed mutagenesis
40. Carbon-13 nuclear magnetic resonance probe of active site ionization of human carbonic anhydrase B
41. The catalytic mechanism of carbonic anhydrase. Hydrogen-isotope effects on the kinetic parameters of the human C isoenzyme
42. Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme
43. Catalysis and inhibition of human carbonic anhydrase IV
44. Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus the cytosolic isozymes